With Global Demand Growing, Fauna Launches New Region Groups, Achieves SOC 2 Compliance, and Adds Sales Leader to Further Accelerate Company Momentum
7.7.2021 16:00:00 EEST | Business Wire | Press release
Fauna, the data API for modern applications, today announced the availability of a new US and European Region Groups and attainment of SOC 2 compliance to support the data residency and regulatory compliance needs of customers. The company also announced the addition of new sales leadership with deep developer and enterprise sales experience. The combination of these new features and sales leadership will help accelerate customer adoption of Fauna globally.
Thus far in 2021 Fauna has experienced 200+% growth in new customers in over 50 countries around the globe. Leveraging Fauna, these companies are bringing disruptive new applications to market more quickly by leaning heavily on the developer productivity that Fauna brings to the table, as well as by foregoing the need to care for and feed traditional database infrastructure.
“As our customer base has grown globally and larger organizations have begun adopting Fauna, it is critical for us to provide additional levels of compliance and more fine grained ways in which customers can manage their data residency needs within Fauna,” said Eric Berg, CEO of Fauna. “The combination of SOC2 compliance and our new Region Groups architecture allows us to meet those needs while still delivering a great developer experience and the zero database operations approach our customers love. Matt Slagle’s addition to the team to scale sales and build out a vibrant partner ecosystem also adds the right leadership and focus to accelerate our business by ensuring customers globally are successful with Fauna.”
New Geographic Region Groups
Unique to Fauna, its new Region Group capability allows global brands to meet local data residency requirements without compromising the performance, latency and reliability gained from distributing data across multiple cloud regions across a geography. Moreover, Region Groups control has been added to the zero operations experience that customers love about Fauna - no database operations required.
Countries around the world have introduced data sovereignty and privacy laws such as the GDPR that require companies to keep application data within the same area from which it was generated. However, to make applications more performant, and resilient, companies also want to bring data closer to their users across multiple cloud regions.
“App developers want to focus on building the app, not worrying about regional and international regulations and restrictions, or building high availability and redundancy services across modern distributed infrastructures,” said James Governor, co-founder of Redmonk. “Making control of data residency easy in specific geographical regions will make life much easier for developers.”
Fauna’s new capabilities address these requirements by enabling companies to pin their databases to a specific geographic area, called a Region Group. Within each Region Group, Fauna automatically distributes and scales these databases across multiple cloud regions within that area to minimize query latency while ensuring data resiliency. All of this is done without any operational overhead for a Fauna customer, continuing to deliver on our zero database operations promise.
Customers have the flexibility to mix and match Region Groups and create databases where the business demands. Developers can start locally within a single Region Group, and add new databases in additional geographic areas as their customer base grows globally.
“Fauna’s new Region Groups break new ground in how and where data is stored and scaled, which has a major impact on performance and data privacy,” said Hassen Karaa, Vice President of Product for Fauna. “We’ve put the right data infrastructure in place in each geographic region to meet our growing customer needs. Moreover, we manage it transparently so that our customers can focus on building applications that scale and comply with their data privacy local regulations and laws.”
SOC 2 Compliance
Data security, availability, confidentiality and reliability are critical considerations for businesses using public cloud infrastructure and SaaS vendors. As a cloud-native API Fauna was built with these in mind.
To demonstrate commitment to these principles Fauna chose the AICPA SOC2 framework of controls and is now SOC 2 Type 1 compliant. Fauna's service commitments and system requirements were achieved based on the trust services criteria relevant to security, availability, and confidentiality. A Type 1 report is available under NDA.
“As we continue to grow our services rapidly across the world, complying with local privacy regulations and data security is essential to our expansion, especially since we work with governments,” said Felix Engelhardt, Lead Engineer at EIDU. “Our use of Fauna has significantly accelerated our ability to bring ideas to market, and the new features being introduced today are critical to support our growth. We applaud Fauna’s innovation and responsiveness to our needs for compliance.”
New Sales Leadership to Drive Customer Success
As part of the company’s efforts to accelerate customer success, Fauna has hired Matt Slagle as its new Vice President of Sales. Slagle joins Fauna from New Relic, where he helped grow the company from less than 100 employees and under $10M in revenue to 2200 employees and ~$700M ARR. In his most recent role he was a Group Vice President of Sales managing a 140 person team that generated $100M+ in revenue.
“I joined Fauna because I recognized the company’s potential to be a major force in data management and app development via a developer focused go to market,” said Slagle. “Customers today love the developer experience and zero database operations that Fauna delivers and I am excited to join the team and help accelerate the focus on customer success.”
About Fauna
Fauna is the data API for modern applications. With Fauna, developers can simplify code, reduce costs, and ship applications faster by replacing their database infrastructure with a highly productive and programmable data API that combines the power of custom business logic with the ease of GraphQL. The underlying globally distributed storage and compute engine is fast, consistent, and reliable, with a modern security infrastructure. Itself a serverless offering, Fauna is quick to get started with and lets developers experience freedom from database operations at any scale. Innovators like Hannon Hill, ShiftX, DigitalAX, and MeetKai trust Fauna to power their applications. Backed by premier venture investors Madrona Venture Group, ADDITION, GV, and CRV, Fauna is headquartered in San Francisco with an experienced leadership team hailing from Microsoft, Okta, Amazon, New Relic, Twitter and Oracle. For more information visit fauna.com or follow us at @fauna.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210707005207/en/
Contact information
Joe Volat, Milestone PR | joe@milestone-pr.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings30.8.2026 15:23:00 EEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new data at the European Society of Cardiology (ESC) Congress 2026 demonstrating the strength of RNAi-powered silencing for cardiovascular disease. The findings further reinforce the clinical profile of AMVUTTRA® (vutrisiran) across transthyretin amyloidosis (ATTR) patient populations, treatment settings, and manifestations of disease. Additionally, the data expand the potential application of RNAi to uncontrolled hypertension, the world’s leading cause of cardiovascular disease. “With the power of our RNAi therapeutics platform, we have the potential to make a transformational impact on cardiovascular care,” said Pushkal Garg, M.D., Chief Research and Development Officer at Alnylam. “The data presented at ESC demonstrate the consistency of clinical outcomes achieved by RNAi-powered TTR silencing, reinforcing our conviction in AMVUTTRA as a first-line treatment option for ATTR-CM. With
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202630.8.2026 00:54:00 EEST | Press release
Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon company, in strategic partnership with the Emirates Falconers’ Club, at ADNEC Centre Abu Dhabi. The exhibition runs until 6 September. The falcon, owned
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 01:40:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the total amount of blood in the body. Maintaining controlled hematocrit levels below 45% is the primary treatment goal in PV.1 “For patients living with PV, uncontrolled hematocrit can have serious consequences, including an elevated risk of life-threatening thrombotic events," said Andrew T. Kuykendall, M.D., VERIFY lead investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “Curre
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 17:00:00 EEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 16:34:00 EEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
